| Beam Communications Holdings Limited (BCC) ORDINARY FULLY PAID |
Information Technology |
$5 |
Full Year FY2026 Result Reports & Appendix 4E
|
21 Aug 2026 9:02AM |
$0.040 |
$0.055 |
risen by
37.50%
|
|
BCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit after tax of AUD 14.3 million for FY2026
- Significant improvement from AUD 13.5 million loss in FY2025
- AUD 12.9 million gain from disposal of interest in ZOLEO Inc.
- Revenues decreased to AUD 18.2 million from AUD 25.7 million
- Cost reductions in product development and arbitration expenses
- AUD 12.1 million capital returned to shareholders
- Net cash from operating activities at AUD 2.4 million
- Directors express confidence in strategic direction
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Digico Infrastructure REIT (DGT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,438 |
DGT Appendix 4E and FY26 Financial Report
|
21 Aug 2026 9:02AM |
$2.790 |
$2.575 |
fallen by
7.71%
|
|
| Eastern Gas Corporation Limited (EGA) ORDINARY FULLY PAID |
Energy |
$4 |
Strong Gas Shows in Venus 2H as it intersects Target Coal
|
21 Aug 2026 9:00AM |
$0.130 |
$0.155 |
risen by
19.23%
|
|
EGA - Price-sensitive ASX Announcement
Full Release
Key Points
- Venus-2H has entered the target Macalister Lower coal seam and is drilling toward Venus-1.
- Drilling encountered intervals with up to 100% coal cuttings and total gas readings up to 25.4%.
- Gas readings above 8% are classified as excellent under the wellsite classification.
- Venus-2H is currently 60 metres from Venus-1, with intersection activities expected soon.
- Once Venus-1 intersection is achieved, drilling will continue to complete the 1000 metres horizontal section.
- The drilling confirms high levels of gas saturation within the target coal along the Venus-2H trajectory.
- Flow-testing program to assess water production, reservoir pressure, gas desorption, and gas flow.
- Eastern Gas to provide updates on significant operational milestones, including flow test results.
- Managing Director expressed confidence in the drilling results and the operational focus on completion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dexus Convenience Retail REIT (DXC) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$376 |
Update - Notification of buy-back - DXC
|
21 Aug 2026 9:00AM |
$2.750 |
$2.770 |
risen by
0.73%
|
|
| Accent Group Limited (AX1) ORDINARY FULLY PAID |
Consumer Discretionary |
$436 |
Supplementary Target's Statement
|
21 Aug 2026 8:59AM |
$0.790 |
$0.725 |
fallen by
8.23%
|
|
AX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Release of Second Supplementary Target's Statement for a takeover by Frasers Group.
- FY26 results report underlying EBIT of $105.3 million and NPAT loss due to goodwill impairment.
- Progress on 2030 Strategic Growth Plan targeting $1.9 billion sales and 9%+ EBIT margin by 2030.
- Key initiatives include closure of loss-making businesses, Sports Direct expansion, and TAF franchise reacquisition.
- Total FY26 sales of $1.64 billion, impacted by geopolitical tensions and consumer confidence.
- The company has a solid financial position with strategic cost-saving measures underway.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Artemis Resources Limited (ARV) ORDINARY FULLY PAID |
Materials |
$17 |
Cleansing Notice
|
21 Aug 2026 8:59AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| Dexus Industria REIT (DXI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$756 |
Update - Notification of buy-back - DXI
|
21 Aug 2026 8:58AM |
$2.370 |
$2.420 |
risen by
2.11%
|
|
| Artemis Resources Limited (ARV) ORDINARY FULLY PAID |
Materials |
$17 |
Notification regarding unquoted securities - ARV
|
21 Aug 2026 8:58AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| Alkane Resources Ltd (ALK) ORDINARY FULLY PAID |
Materials |
$2,681 |
Notification of buy-back - ALK
|
21 Aug 2026 8:58AM |
$1.770 |
$1.963 |
risen by
10.88%
|
|
| Alkane Resources Ltd (ALK) ORDINARY FULLY PAID |
Materials |
$2,681 |
Dividend/Distribution - ALK
|
21 Aug 2026 8:58AM |
$1.770 |
$1.963 |
risen by
10.88%
|
|
| Astral Resources NL (AAR) ORDINARY FULLY PAID |
Materials |
$369 |
Think Big Infill Drilling Confirms High Grade Mineralisation
|
21 Aug 2026 8:57AM |
$0.185 |
$0.205 |
risen by
10.81%
|
|
AAR - Price-sensitive ASX Announcement
Full Release
Key Points
- 92-hole in-fill RC drilling program completed at Think Big deposit.
- Best assay results include significant gold grades such as 11m at 7.34g/t Au and 12m at 5.89g/t Au.
- In-fill drilling confirms presence of shallow, high-grade supergene mineralisation.
- Native Vegetation Clearing Permit received for development under a Joint Venture with MMS.
- Mineralised wireframes update in progress for grade control model.
- Mine development approvals progressing with resolved objections on miscellaneous license application.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Accent Group Limited (AX1) ORDINARY FULLY PAID |
Consumer Discretionary |
$436 |
Appendix 4G and FY26 Corporate Governance Statement
|
21 Aug 2026 8:57AM |
$0.790 |
$0.725 |
fallen by
8.23%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$136 |
Island boosts Galidesivir supply as Ebola surges
|
21 Aug 2026 8:56AM |
$0.460 |
$0.460 |
fallen by
0%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Island Pharmaceuticals Limited has commissioned a second manufacturing campaign of GMP-grade Galidesivir to expand its supply.
- This decision is strategic to address the ongoing Bundibugyo Ebola outbreak in Central Africa.
- The outbreak has reported 5,208 confirmed cases and 2,476 deaths as of 18 August 2026.
- Galidesivir is positioned as a broad-spectrum antiviral and biodefense countermeasure.
- The company plans to deploy Galidesivir under the WHO's MEURI framework in Uganda during CY26.
- Approximately 700-800 treatment courses of Galidesivir will be available by Q4 CY26.
- Galidesivir has demonstrated strong efficacy in non-human primate models for multiple filoviruses.
- The company's strategy includes engaging with governments and biodefense agencies for procurement and stockpiling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Djerriwarrh Investments Limited (DJW) ORDINARY FULLY PAID |
Financials |
$792 |
Update - Notification of buy-back - DJW
|
21 Aug 2026 8:56AM |
$2.990 |
$3.030 |
risen by
1.34%
|
|
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,796 |
Opening of Share Purchase Plan
|
21 Aug 2026 8:56AM |
$3.260 |
$3.250 |
fallen by
0.31%
|
|
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,455 |
Update - Notification of buy-back - AFI
|
21 Aug 2026 8:55AM |
$6.840 |
$6.890 |
risen by
0.73%
|
|
| Ama Group Limited (AMA) ORDINARY FULLY PAID |
Industrials |
$219 |
FY26 Results Presentation
|
21 Aug 2026 8:54AM |
$0.460 |
$0.455 |
fallen by
1.09%
|
|
AMA - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue of $1,039.1 million in FY26.
- Normalised pre-AASB 16 EBITDA increased by 8.6% to $68.0 million.
- Capital SMART achieved a Normalised EBITDA margin of 10.6%.
- Challenges due to elevated fuel prices affecting Q4 repair volumes.
- Growth in volume, revenue, and profitability in AMA Collision and Specialist businesses.
- Strategic investments facilitated by strong balance sheet and reduced net debt.
- Anticipated improvements in EBITDA margins and profitability for FY27.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Artemis Resources Limited (ARV) ORDINARY FULLY PAID |
Materials |
$17 |
Notification regarding unquoted securities - ARV
|
21 Aug 2026 8:53AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| Digico Infrastructure REIT (DGT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,438 |
Leadership Transition
|
21 Aug 2026 8:53AM |
$2.790 |
$2.575 |
fallen by
7.71%
|
|
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$703 |
Update - Dividend/Distribution - KKC
|
21 Aug 2026 8:52AM |
$2.160 |
$2.180 |
risen by
0.93%
|
|
| Ama Group Limited (AMA) ORDINARY FULLY PAID |
Industrials |
$219 |
FY26 Results Release
|
21 Aug 2026 8:52AM |
$0.460 |
$0.455 |
fallen by
1.09%
|
|
AMA - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue of $1,039.1 million in FY26.
- Normalised pre-AASB 16 EBITDA increased to $68.0 million.
- Net profit after tax of $7.7 million versus a net loss in FY25.
- First dividend declared since 2019, fully franked at 0.5 cents per share.
- Continued growth in Capital SMART and AMA Collision segments.
- Increased profitability in Specialist Businesses and ACM Parts.
- Vertically integrated operations providing competitive advantage.
- FY27 outlook anticipates further growth and network optimizations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$193 |
Xolatryp Demonstrates Cardioprotection in Preclinical Study
|
21 Aug 2026 8:50AM |
$0.740 |
$0.780 |
risen by
5.41%
|
|
NYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Xolatryp significantly protected cardiac function against doxorubicin-induced cardiotoxicity.
- The magnitude of functional protection was comparable to dexrazoxane.
- Xolatryp provided sustained protection over five weeks in the study.
- Xolatryp showed anti-tumour activity alone and synergistically with doxorubicin.
- Nyrada plans further clinical trials to explore Xolatryp's potential in oncology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Accent Group Limited (AX1) ORDINARY FULLY PAID |
Consumer Discretionary |
$436 |
FY26 Full Year Investor Presentation
|
21 Aug 2026 8:50AM |
$0.790 |
$0.725 |
fallen by
8.23%
|
|
AX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Accent Group FY26 results presentation covers performance for the year ending on 28 June 2026.
- The company demonstrated growth with a total sales increase to $1.6 billion, marking a 0.9% rise from FY25.
- Retail sales reached $1.4 billion, showing a 4.0% increase from FY25, despite challenging economic conditions.
- Wholesale sales also grew by 10.8%, contributing positively to overall performance.
- Accent Group expanded its store network by opening 43 new stores, totaling 876 stores across Australia and New Zealand.
- The strategic focus included the closure of loss-making businesses and underperforming brand exits.
- Key financial highlights include an underlying EBIT of $105.3 million for FY26.
- The company is progressing with its 2030 Strategic Growth Plan targeting operational efficiencies and growth investments.
- Sports Direct was launched and expanded, with improvements in margins and plans for further growth.
- A final dividend of 1.25 cents per share was declared, with total dividends for FY26 at 4.50 cents per share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ama Group Limited (AMA) ORDINARY FULLY PAID |
Industrials |
$219 |
FY26 Corporate Governance Statement
|
21 Aug 2026 8:49AM |
$0.460 |
$0.455 |
fallen by
1.09%
|
|
| Artemis Resources Limited (ARV) ORDINARY FULLY PAID |
Materials |
$17 |
Notification regarding unquoted securities - ARV
|
21 Aug 2026 8:49AM |
$0.004 |
$0.003 |
fallen by
25%
|
|